Germing U - Search Results

1

MPL 515 and JAK2 mutation analysis in MDS presenting with a platelet count of more than 500 x 10(9)/l.

Zipperer E, Wulfert M, Germing U, Haas R, Gattermann N. Zipperer E, et al. Among authors: germing u. Ann Hematol. 2008 May;87(5):413-5. doi: 10.1007/s00277-007-0409-0. Epub 2007 Nov 27. Ann Hematol. 2008. PMID: 18040685 No abstract available.

2

[Myelodysplastic syndromes. The epidemiological and etiological aspects].

Aul C, Gattermann N, Germing U, Runde V, Heyll A. Aul C, et al. Among authors: germing u. Dtsch Med Wochenschr. 1992 Aug 14;117(33):1223-31. doi: 10.1055/s-2008-1062434. Dtsch Med Wochenschr. 1992. PMID: 1499520 German.

3

Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.

Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W. Aul C, et al. Among authors: germing u. Leukemia. 1992 Jan;6(1):52-9. Leukemia. 1992. PMID: 1736014

4

Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf score.

Aul C, Gattermann N, Germing U, Runde V, Heyll A, Schneider W. Aul C, et al. Among authors: germing u. Leukemia. 1994 Nov;8(11):1906-13. Leukemia. 1994. PMID: 7967735

5

Serum deoxythymidine kinase in myelodysplastic syndromes.

Aul C, Gattermann N, Germing U, Winkelmann M, Heyll A, Runde V, Schneider W. Aul C, et al. Among authors: germing u. Cancer. 1994 Jan 15;73(2):322-7. doi: 10.1002/1097-0142(19940115)73:2<322::aid-cncr2820730215>3.0.co;2-e. Cancer. 1994. PMID: 8293395

6

[The prognostic significance of serum thymidine kinase in the myelodysplastic syndrome].

Aul C, Germing U, Gattermann N, Söhngen D, Heyll A. Aul C, et al. Among authors: germing u. Dtsch Med Wochenschr. 1996 Sep 13;121(37):1113-8. doi: 10.1055/s-2008-1043114. Dtsch Med Wochenschr. 1996. PMID: 8925725 German.

7

Increasing incidence of myelodysplastic syndromes: real or fictitious?

Aul C, Germing U, Gattermann N, Minning H. Aul C, et al. Among authors: germing u. Leuk Res. 1998 Jan;22(1):93-100. doi: 10.1016/s0145-2126(97)00089-1. Leuk Res. 1998. PMID: 9585086

8

[Role of aggressive treatment strategies for myelodysplastic syndromes].

Aul C, Germing U, Minning H, Kobbe G, Gattermann N, Südhoff T, Meckenstock G, Söhngen D, Heyll A. Aul C, et al. Among authors: germing u. Praxis (Bern 1994). 1999 Mar 4;88(10):431-8. Praxis (Bern 1994). 1999. PMID: 10199215 Review. German.

9

Two types of acquired idiopathic sideroblastic anaemia (AISA): a time-tested distinction.

Germing U, Gattermann N, Aivado M, Hildebrandt B, Aul C. Germing U, et al. Br J Haematol. 2000 Mar;108(4):724-8. doi: 10.1046/j.1365-2141.2000.01940.x. Br J Haematol. 2000. PMID: 10792275 Free article.

10

[Aspects of internal medicine].

Haas R, Germing U. Haas R, et al. Among authors: germing u. Radiologe. 2000 Jun;40(6):495-9. doi: 10.1007/s001170050746. Radiologe. 2000. PMID: 10929385 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

439 results

Search Page

Filters